2009•International Archives of Allergy and Applied ImmunologyRequires access

Low-Affinity Receptor for IgE (FcERII, CD23) and Its Soluble Fragments

G Delespesse, Heike Hofstetter, Marika Sarfati

Open publisher page 19 citations

Abstract

The low-affinity receptor for IgE (FcERII or CD23) is a membrane 45-kD glycoprotein which is cleaved by an autoproteolytic mechanism into soluble 37-, 33- and 25-kD fragments that are capable of binding to IgE (IgE-binding factors, IgE-BFs). FcERIIa (which is expressed only on fresh B cells) differs from FcERIIb (which is expressed on IL4-stimulated B cells, monocytes, eosinophils and T cells) by a few intracytoplasmic amino acids. The only function of FcERII which is clearly demonstrated is the IgE-dependent cytotoxicity of FcERIIb on monocytes and eosinophils. We here review our recent observations indicating that 37-kD IgE-BFs regulate the synthesis of human IgE. Recombinant 37-kD IgE-BFs increase the IL4-induced synthesis of IgE by peripheral blood lymphocytes, as well as the IL4-independent, ongoing synthesis of IgE by either in vivo activated B cells from allergic patients or by in vitro IL4-preactivated B cells.

About this research paper

What this paper is about

The low-affinity receptor for IgE (FcERII or CD23) is a membrane 45-kD glycoprotein which is cleaved by an autoproteolytic mechanism into soluble 37-, 33- and 25-kD fragments that are capable of binding to IgE (IgE-binding factors, IgE-BFs). FcERIIa (which is expressed only on fresh B cells) differs from FcERIIb (which is expressed on IL4-stimulated B cells, monocytes, eosinophils and T cells) by a few intracytoplasmic amino acids. The only function of FcERII which is clearly demonstrated is the IgE-dependent cytotoxicity of FcERIIb on monocytes and eosinophils. We here review our recent observations indicating that 37-kD IgE-BFs regulate the synthesis of human IgE. Recombinant 37-kD IgE-BFs increase the IL4-induced synthesis of IgE by peripheral blood lymphocytes, as well as the IL4-independent, ongoing synthesis of IgE by either in vivo activated B cells from allergic patients or by in vitro IL4-preactivated B cells.

Why it matters

OpenAlex reports 19 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The low-affinity receptor for IgE (FcERII or CD23) is a membrane 45-kD glycoprotein which is cleaved by an autoproteolytic mechanism into soluble 37-, 33- and 25-kD fragments that are capable of binding to IgE (IgE-binding factors, IgE-BFs). FcERIIa (which is expressed only on fresh B cells) differs from FcERIIb (which is expressed on IL4-stimulated B cells, monocytes, eosinophils and T cells) by a few intracytoplasmic amino acids. The only function of FcERII which is clearly demonstrated is the IgE-dependent cytotoxicity of FcERIIb on monocytes and eosinophils. We here review our recent observations indicating that 37-kD IgE-BFs regulate the synthesis of human IgE. Recombinant 37-kD IgE-BFs increase the IL4-induced synthesis of IgE by peripheral blood lymphocytes, as well as the IL4-independent, ongoing synthesis of IgE by either in vivo activated B cells from allergic patients or by in vitro IL4-preactivated B cells.

Key concepts: CD23, Immunoglobulin E, Immunology, Receptor, Chemistry, Biology, Antibody, Biochemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Low-Affinity Receptor for IgE (FcERII, CD23) and Its Soluble Fragments — Research Paper | ScholarLens